Finance

Lists
Why is 300871 down 2,09%?
Dive Deeper
300871:SHE
Wuhan Hvsen Biotechnology Co Ltd
CN¥19,66
-2,09%
(-0,42) 1D
14 Okt., 15:04:10 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300871...
Open
CN¥19,98
High
CN¥20,06
Low
CN¥19,55
Mkt. cap
4,05 mjd
Avg. vol.
3,88 m
Volume
2,40 m
Dividend
2,54%
Quarterly dividend
CN¥0,13
Ex-dividend date
08 Sep. 2026
P/E ratio
11,90
52-wk high
CN¥32,62
52-wk low
CN¥19,08
EPS
CN¥1,65
Shares outstanding
201,78 m
No. of employees
1 k
Open
CN¥19,98
High
CN¥20,06
Low
CN¥19,55
Mkt. cap
4,05 mjd
Avg. vol.
3,88 m
Volume
2,40 m
Dividend
2,54%
Quarterly dividend
CN¥0,13
Ex-dividend date
08 Sep. 2026
P/E ratio
11,90
52-wk high
CN¥32,62
52-wk low
CN¥19,08
EPS
CN¥1,65
Shares outstanding
201,78 m
No. of employees
1 k
News stories
From web sources and news partners
About Wuhan Hvsen Biotechnology Co Ltd
CEO-
Employees1,13 k
Founded25 Jan. 2002
Headquarters-
SectorPharmaceutical industry
Websitewhhsyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
437,33 m
421,71 m
458,22 m
406,71 m
Cost of goods sold
291,81 m
272,85 m
295,49 m
263,77 m
Cost of revenue
291,81 m
272,85 m
295,49 m
263,77 m
Research and development expenses
22,49 m
25,79 m
24,40 m
29,37 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,97 m
46,04 m
40,32 m
41,37 m
Operating expense
51,63 m
86,98 m
67,51 m
74,25 m
Total operating expenses
343,44 m
359,83 m
363,01 m
338,01 m
Operating income
93,90 m
61,89 m
95,21 m
68,70 m
Other non operating income
-2,21 m
-354,51 k
927,61 k
-4,63 m
EBT including unusual items
81,01 m
74,07 m
87,34 m
146,26 m
EBT excluding unusual items
92,63 m
63,52 m
97,69 m
61,63 m
Income tax expense
10,07 m
9,06 m
9,10 m
18,06 m
Effective tax rate
12,44%
12,24%
10,41%
12,35%
Other operating expenses
-12,11 m
14,44 m
711,37 k
4,69 m
Net income
70,72 m
65,25 m
77,67 m
128,09 m
Net profit margin
16,17%
15,47%
16,95%
31,49%
Earnings per share
-
-
-
-
Interest and investment income
2,02 m
4,30 m
1,55 m
30,40 k
Interest expense
-512,99 k
-1,48 m
-
-75,19 k
Net interest expenses
1,50 m
2,82 m
1,55 m
-44,79 k
Depreciation and amortization charges
-
-
-
-
EBITDA
122,18 m
91,96 m
125,29 m
100,14 m
Gain or loss from assets sale
-
-
-
-51,32 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme